Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rectopexy Outcome Study (RPE): Clinical Outcomes After Rectopexy for Rectal Prolapse

NCT07848308 is registered in ClinicalTrials.gov with Lukas Marti as lead sponsor.

NCT NCT07848308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rectopexy Outcome Study (RPE): Clinical Outcomes After Rectopexy for Rectal Prolapse
Lead sponsor
Lukas Marti
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2011
Completion date
December 31, 2035
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal incontinence, intussusception of rectum, obstructive defecation syndrome, rectal prolapse, rectopexy